(Q44442888)

3 December 2017

Acyclic N-(azacycloalkyl)bisindolylmaleimides: isozyme selective inhibitors of PKCbeta (English)

1 reference

3 December 2017

Acyclic N-(azacycloalkyl)bisindolylmaleimides: isozyme selective inhibitors of PKCβ (English)

1 reference

https://api.crossref.org/works/10.1016/S0960-894X(03)00286-5

2 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0960-894X(03)00286-5

2 January 2024

pharmaceutical science

1 reference

https://api.crossref.org/works/10.1016/S0960-894X(03)00286-5

2 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0960-894X(03)00286-5

2 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0960-894X(03)00286-5

2 January 2024

author name string

Theo Schotten

5

1 reference

3 December 2017

Astrid Kahl

6

1 reference

3 December 2017

Michael Mohr

7

1 reference

3 December 2017

Margaret M. Faul

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12749884

2 January 2024

James R. Gillig

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12749884

2 January 2024

Michael R. Jirousek

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12749884

2 January 2024

Lawrence M. Ballas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12749884

2 January 2024

language of work or name

English

0 references

publication date

1 June 2003

1 reference

3 December 2017

2 June 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12749884

2 January 2024

number of pages

3

1 reference

full work available at URL

inferred from page(s)

https://api.elsevier.com/content/article/PII:S0960894X03002865?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0960-894X(03)00286-5

https://api.elsevier.com/content/article/PII:S0960894X03002865?httpAccept=text/plain

2 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0960-894X(03)00286-5

Bioorganic & Medicinal Chemistry Letters

2 January 2024

published in

1 reference

3 December 2017

13

1 reference

3 December 2017

1857-1859

1 reference

3 December 2017

11

1 reference

Protein kinase C as a drug target: implications for drug or diet prevention and treatment of cancer

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900286-5

7 January 2021

Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900286-5

7 January 2021

Role of protein kinase C isozymes in cellular functions and pathological conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900286-5

7 January 2021

Protein kinase C inhibitors as novel anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900286-5

7 January 2021

(S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900286-5

7 January 2021

A calcium/calmodulin-dependent protein kinase from mammalian brain that phosphorylates Synapsin I: partial purification and characterization.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900286-5

7 January 2021

Identifiers

1 reference

3 December 2017

1 reference